CRC with low TRAIL-R1 expression also showed a poor 5 year overall survival of 53.9% as compared to 68.1% with high TRAIL-R1 expression (p = 0.0124; Figure 5A). Here, TNFRSF10A is linked to colorectal carcinoma.